Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 28, 2000
Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutritionD Shemin, A G Bostom, C Lambert, et al.Atherosclerosis|February 1, 1996
Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patientsA G Bostom, D Shemin, D Yoburn, et al.Kidney International|January 3, 2001
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patientsA Yango, D Shemin, N Hsu, et al.Journal of the American Society of Nephrology : JASN|May 8, 1999
Plasma total homocysteine and hemodialysis access thrombosis: a prospective studyD Shemin, K L Lapane, L Bausserman, et al.Transplantation|June 14, 2000
Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patientsA G Bostom, D Shemin, R Y Gohh, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective studyA G Bostom, D Shemin, P Verhoef, et al.Advances in Renal Replacement Therapy|October 29, 2000
First hemodialysis access selection varies with patient acuityA L Friedman, C Walworth, C Meehan, et al.Circulation|June 22, 2000
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patientsA G Bostom, D Shemin, P Bagley, et al.Kidney International. Supplement|February 13, 2001
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipientsA G Bostom, D Shemin, R Y Gohh, et al.Kidney International|January 1, 1996
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patientsA G Bostom, D Shemin, K L Lapane, et al.Pageof 7